Jan 21, 2020

SIGNIFY: Ivabradine no help in stable CAD | MDedge Cardiology

Key clinical point: The investigational drug ivabradine did not improve outcomes in stable CAD patients with no heart failure.Major finding: No significant difference was seen between ivabradine and placebo; HR for composite endpoint of death from cardiovascular causes or nonfatal MI, 1.08.Data sour

Proceed to the page: http://linkis.com/zHXPc

Similar Articles Added Earlier

Similar Articles Added Today

Most Recent mdedge.com Articles

Latest Links Processed